AzTrials
AzTrials

ContraceptionNCT04717596

Implementation and Examination of Contraception Care for Hospitalized Adolescents With Mental Health Disorders

An observational study of Contraception, run by Elise Berlan at 1 site in United States.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

This study is a hybrid trial that examines both the clinical effectiveness and the implementation of BC4Teens Contraception Care. The investigators use a naturalistic one-group longitudinal study design to maximize feasibility and external validity, which is important for understanding implementation and effectiveness… Read more about this study

Who is it for?
Ages 14 years and older, women only
Conditions the study is for
Contraception
What is being tested?
BC4Teens Care
How many people
455 participants
Where
1 siteUnited States
Study dates
7 Apr 2021to 15 Sep 2023
Phase
Observational
Are there results?
Yes, posted in the registrySummary in the doctors' view

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 14 years and older
  • Women only
  • No healthy volunteers
  • Child, Adult, Older adult

Study population: female adolescents hospitalized for mental health disorder on Psychiatric Unit, Youth Crisis Stabilization Unit (YCSU), Psychiatric Crisis Department Extended Observation Care Unit, and Hospital Pediatrics service at Nationwide Children's Hospital

Who may be able to join

  • female adolescents, ages 14 and up, receiving care in Psychiatric Unit, Youth Crisis Stabilization Unit (YCSU), Psychiatric Crisis Department Extended Observation Care Unit, and Hospital Pediatrics service

Who cannot join

  • unable to consent due to mental health disorder, serious medical condition, non-English speaking, known pregnancy

Trial locations and contacts

1 site in 1 country.

United States1 site
  • Nationwide Children's Hospital

    Columbus, Ohio, 43205

Other trials in United States

About this study

This study is a hybrid trial that examines both the clinical effectiveness and the implementation of BC4Teens Contraception Care. The investigators use a naturalistic one-group longitudinal study design to maximize feasibility and external validity, which is important for understanding implementation and effectiveness in real-world service delivery settings.

Read the detailed description

Approximately one in five American youth have experienced severe impairment due to mental health disorders, with anxiety and mood disorders being most common among female adolescents. Mental health disorders are associated with a range of sexual risk behaviors and unintended pregnancy. Youth with mental health disorders have higher rates of condom and contraception non-use (especially short acting), earlier sexual debut, and higher fertility rates.

Avoiding an unwanted or unintended pregnancy is particularly important for women with underlying mental health disorders. Experiencing a pregnancy exacerbates underlying mental health disorders in women with mental health disorder. And children born out of an unintended pregnancy or in context of mother with active mental health disorder face additional risks to their wellbeing. Long acting reversible contraceptives (LARCs), i.e. contraceptive implants and intrauterine devices, have attributes that may be particularly attractive to adolescents with mental health disorders. In particular, they are highly effective and do not require ongoing maintenance. However, adolescents with mental health disorders face multiple barriers to accessing contraception care. Novel solutions are needed to improve access to contraception care, including LARC, for adolescents with mental disorders.

The inpatient pediatric hospitalization setting is a missed opportunity for improving adolescent sexual and reproductive health. Nearly 10% of pediatric hospitalizations are for a primary mental health diagnosis, and mood disorders are the most common primary mental health diagnosis among these hospitalizations. Sexual and reproductive healthcare is rarely provided to hospitalized adolescents. At Nationwide Children's Hospital, a chart audit completed in December 2019 found that no adolescents hospitalized for mental health disorders on the Hospital Pediatrics service had documentation they were screened for sexual activity.

Adolescents are interested in learning about sexual and reproductive health and receiving sexual and reproductive healthcare in the hospital setting regardless of age, gender, and prior sexual experiences. Two studies of pediatric hospitalists found that the majority of those physicians felt that sexual and reproductive services are appropriate for hospitalized adolescents, with high support for referrals and starting contraception in the hospital. Numerous barriers to inpatient provision of contraceptives/sexual reproductive healthcare were endorsed, including: concerns about follow up after discharge, lack of knowledge about confidentiality, lack of knowledge about contraception, interference with the treatment plan, time constraints, and pregnancy risk in lesbian, gay, bisexual, and transgender youth. Riese et al. conducted a trial of an interactive patient-facing electronic sexual health module and found that it was acceptable to adolescents and their parents, and that most participants requested a sexual health service after completing the module. (The most requested service was viewing a contraception video made by this PI.) There are no published studies of interventions to improve contraception care to hospitalized adolescents with mental health disorders.

The PI designed an adolescent-friendly contraceptive counseling training course, called BC4Teens Counseling, in use since 2014 by outpatient family planning clinicians in BC4Teens Clinic at Nationwide Children's Hospital, the second largest children's hospital in the US. BC4Teens Counseling is adapted from Contraceptive Choice Project materials and employs efficacy-based counseling, which is endorsed by WHO and American Academy of Pediatrics. This training will be adapted to current best practice recommendations, including shared-decision making. The PI, with a multidisciplinary team, has also designed a comprehensive Contraception Clinical Guideline, contraception initiation job aid, and electronic health record order set with decision support for contraception initiation. These are currently used in outpatient care across several departments at Nationwide Children's Hospital. The PI is a Nexplanon Clinical Trainer and has extensive experience with clinical teaching on contraception care and Nexplanon procedures, and this site is a Merck Center of Experience.

The investigators propose the following BC4Teens Contraception Care Intervention. All healthcare professionals participating the intervention will receive training in the following:

  • BC4Teens Counseling is a set of adolescent-friendly contraception counseling and provision protocols for all FDA-approved prescription contraceptives. The training includes up-to-date information about maintaining adolescent confidentiality, coding, and care for sexually transmitted infections.
  • Nationwide Children's Contraception Clinical Guideline, a contraception initiation job aid, and electronic health record order set and decision support for contraception initiation. These materials are evidence-based and reference established best practices for contraception care, pregnancy options counseling, and preconception care.
  • Nexplanon Clinical Training and credentialing in Nexplanon procedures during planning phase.
  • Information about institutional policies, adolescent confidentiality and consent, and local sexual health resources will be provided to participating healthcare professionals.
  • Ongoing technical and procedural support from institutional BC4Teens expert trainer.

More than 2000 female adolescents with mental health disorders were hospitalized in 2019 at Nationwide Children's Hospital. In February 2020 The Big Lots Behavioral Health Pavilion (BHP) at Nationwide Children's Hospital opened its doors. The BHP is America's largest center dedicated exclusively to child and adolescent behavioral and mental health on a pediatric medical campus. Due to the impact of COVID and the simultaneous opening of the BHP, adolescents with mental health disorders are now hospitalized differently within the Nationwide Children's Hospital system than before. Presently at Nationwide Children's Hospital adolescents with mental health disorders are admitted to the Psychiatry Unit, the observation unit of the psychiatric crisis department, or the Youth Crisis Stabilization Unit (YCSU). The investigators anticipate that once the initial COVID impact has passed, adolescent patients with mental health disorders may overflow onto the Hospital Pediatrics service within the main hospital as they previously did.

The primary goal of this study is to examine an intervention to improve access to contraception care among female adolescents hospitalized with mental health disorders within Nationwide Children's Hospital.

One of the investigators' long term goals is to scale-up effective contraceptive counseling interventions like BC4Teens Contraception Care beyond Nationwide Children's Hospital to other inpatient settings. This type of scale up has potential to expand the reach of contraceptive care to a broader population of adolescent females with mental health concerns. However, evidence-based psychosocial interventions sometimes fail to yield the same benefits observed in controlled studies when they are transported to new settings. Limited resources, poor alignment with organizational structures and missions, concerns about the interventions' acceptability, and heterogeneity of patient needs and professional skill can lead to difficulty delivering the intervention with fidelity (as it was intended with all core components and at prescribed dosage). This "voltage drop" in intervention effectiveness as it moves into routine care is often attributed to failure to optimize the intervention in its new context.

In this study, the secondary goal is to examine the strategies and processes used to implement BC4Teens at Nationwide Children's Hospital, and create an implementation manual that can be used to scale up this intervention in other settings. Thus, the investigators are embedding a naturalistic observational study of BC4Teens implementation within the effectiveness research. This study component will focus on specifying the procedures used to tailor the intervention and training supports, and monitoring the outcomes of implementation (including the degree to which professionals adopt BC4Teens, deliver it with fidelity, and reach the target population). In addition to informing an implementation manual, these results will also advance understanding of the model including the degree to which the model must be delivered as intended in order to generate clinical benefit, identify types of professionals best suited for delivering BC4Teens, and patients for whom this intervention is considered acceptable.

Conditions
Contraception
Being tested
BC4Teens Care

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • BC4Teens CareOther

    Healthcare providers will be trained in contraceptive counseling and provision.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Interest BC4Teens Care

    % participants who answer yes to the following question "Interest in learning more about contraception during your hospital stay". Investigators will calculate the percentage of participants who answer yes to the Interest in Contraption Initiation question.

    Measured: Baseline

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted22 Jan 2021
  2. Study start7 Apr 2021
  3. Primary completion1 Aug 2023
  4. Study completion15 Sep 2023

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Other
Time perspective
Cross-sectional
Enrolment
455 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04717596
Sponsor's protocol ID
STUDY00001603
Status last verified
Jul 2024
First submitted
13 Jan 2021
Last updated
10 Oct 2024
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No: IPD will not be shared outside of the research team.

Questions about this trial

What is this clinical trial studying?

An observational study of Contraception, run by Elise Berlan at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 10 Oct 2024. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Yes. Results are posted in the registry (first posted 10 Oct 2024). A summary is in the For doctors view, and the full results are on ClinicalTrials.gov.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Interest BC4Teens Care (time frame: Baseline). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 10 Oct 2024.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in